News
Pfizer and Moderna will now include more information on the risk of myocarditis on their COVID-19 vaccine labels.
Opinion
19hon MSNOpinion
If RFK has his way, even if you still have coverage, you may not be able to afford the shots that your doctor wants to give.
Pfizer’s announcement about the effectiveness of its Covid-19 vaccine came nearly a week after Election Day, but Pfizer CEO Albert Bourla has said the timing had nothing to do with politics.
Vijay Deverakonda Addresses Backlash Over Adding 'The' To His Name: Everyone Has Tagline, Nobody Else Gets Backlash How to ...
Moderna shares surged 9.5% amid legal backlash against vaccine policy changes. Will it be a turning point for MRNA which is ...
According to Bloomberg, citing an email sent by Chief Executive Officer Albert Bourla on Tuesday, Susman’s responsibilities ...
The most powerful EU official faces a challenge to her authority, if not her hold on office, thanks to a censure motion. Center-left EU lawmakers seized the moment to slam cooperation with the far ...
Complications from a Covid infection can harm the heart, brain, lungs and kidneys. A new study finds that patients hospitalized for Covid were less likely to suffer severe kidney damage if they ...
The Covid-19 vaccines can also protect the newborn—one of the highest-risk groups for hospitalization—since taking a dose during pregnancy confers maternal antibodies to the fetus, Faust says.
The American Pharmacists Association announced Monday it will withhold endorsement of the Centers for Disease Control and Prevention’s updated immunization schedule that removed COVID-19 vaccine ...
Hosted on MSN14d
Pfizer’s Phase 3 Study on Ibuzatrelvir: A Potential Game Changer in COVID-19 Treatment - MSNPfizer Inc. is conducting a Phase 3 clinical study titled ‘An Interventional Efficacy and Safety, Phase 3, Double-Blind, 2-Arm Study to Investigate Orally Administered Ibuzatrelvir Compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results